Olmez, O. F. Et Al. 2019. Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.6 , 1526-1530.

Olmez, O. F., Kinikoglu, O., Yilmaz, N. H., Bilici, A., ÇUBUKÇU, E., Seker, M., ... ÇAKIR, T.(2019). Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.6, 1526-1530.

Olmez, Omer Et Al. "Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.6, 1526-1530, 2019

Olmez, Omer F. Et Al. "Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.6, pp.1526-1530, 2019

Olmez, O. F. Et Al. (2019) . "Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.6, pp.1526-1530.

@article{article, author={Omer Fatih Olmez Et Al. }, title={Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2019, pages={1526-1530} }